プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Omololu F.に依頼

United Kingdom

Interdisciplinary Scientist | Biotechnology, Data Analysis, Bioinformatics, Microbiology and Scientific Writing

プロフィール概要

I am an interdisciplinary scientist with experience across microbiology, computational biology, biotechnology, data analysis, and scientific communication. I support academic, biotech, life science, and innovation-focused projects through research design, data interpretation, bioinformatics, molecular analysis, technical writing, and scientific strategy. My work combines laboratory understanding with computational and analytical skills, allowing me to contribute across diverse scientific and technology-driven projects. I am particularly interested in translating complex data into clear insights that support research, product development, decision-making, and innovation in health, biological, and applied science sectors.

専門分野

• ☆ Biotechnology & Bioengineering
• ☆ Nanobiotechnology
• ☆ Microbial Biotechnology
• ☆ Industrial Biotechnology
• ☆ Higher Education
• ☆ Python
• ☆ SPSS
• ☆ SQL
• ☆ Excel
• ☆ Java
• ☆ SAS
• ☆ Tensorflow
• ☆ R
• ☆ Tableau
• ☆ Scikit-learn
• ☆ Drug Discovery
• ☆ Drug Target Identification
• ☆ Hit-to-Lead & Lead Optimization
• ☆ Hypothesis
• ☆ Peer Review
• ☆ Research Methodology
• ☆ Survey Design & Methodology
• ☆ User Research
• ☆ Quantitative User Research
• ☆ Qualitative User Research
• ☆ Meta-Research
• ☆ Technology Scouting
• ☆ Fact Checking
• ☆ Literature Search
• ☆ Gap Analysis
• ☆ Gray Literature Search
• ☆ Scientific Proofreading & Editing
• ☆ Grant Writing
• ☆ Personal Care Product Formulation

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Non-Medical Regulatory Writing, Technical Writing, General Proofreading & Editing

Research Meta-Research, Feasibility Study, Technology Scouting, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Healthcare Consulting, Scientific and Technical Consulting, Regulatory Consulting

Data & AI Predictive Modeling, Statistical Analysis, Algorithm Design-Non ML, Algorithm Design-ML, Data Visualization, Big Data Analytics, Text Mining & Analytics, Data Mining, Data Cleaning, Data Processing, Data Insights

Product Development Formulation, Recipe Development, Product Evaluation, Quality Assurance & Control (QA/QC)

職務経験

Queen's University Belfast

- 現在

Lead Bioinformatician

Sequential Skin Ltd

3月 2026 - 現在

Research Fellow

Queens University of Belfast

9月 2022 - 現在

Researcher

University of Huddersfield School of Applied Sciences

9月 2017 - 現在

Scientific Officer/ Supply Chain (Pharmaceutical Products)

Federal Ministry of Health

12月 2010 - 現在

Assistant Medical laboratory Scientist. Carrying out routine laboratory diagnosis of patient for disease conditions

PHCN Hospital,

3月 2009 - 2月 2010

学歴

PhD Applied Sciences

University of Huddersfield

9月 2017 - 現在

University of Lincoln

8月 2015 - 7月 2016

M.Sc Biotechnology (Health and Life Sciences)

Coventry University Faculty of Health and Life Sciences

9月 2011 - 8月 2012

B.Sc(Hons) Microbiology (MICROBIOLOGY)

Olabisi Onabanjo University

11月 2003 - 4月 2007

認定資格

• Specialist in Microbiology

  University of Huddersfield

  6月 2022 - 現在

出版物

REVIEW

Climate change as a challenge for pharmaceutical storage and tackling antimicrobial resistance @article{e2e1ef8a2bd04026b19f0bdede28c976, title = "Climate change as a challenge for pharmaceutical storage and tackling antimicrobial resistance", abstract = "The rise of antimicrobial resistance (AMR) remains a pressing global health challenge. Infections that were once easily treatable with first-line antimicrobials are becoming increasingly difficult to manage. This shift directly threatens the wellness of humans, animals, plants, and the environment. While the AMR crisis can be attributed to a myriad of factors, including lack of infection prevention and control measures, over-prescription of antimicrobials, patient non-compliance, and the misuse of antimicrobials, one aspect that has garnered less attention is the role of storage conditions of these medicines. The way medications, particularly antimicrobials, are transported and stored until the point of use can influence their efficacy and, subsequently, may impact the development of resistant microbial strains. This review delves deeper into the often-overlooked domain of climate change (CC) and antimicrobial storage practices and the potential effects. Inappropriate storage conditions, such as exposure to extreme temperatures, humidity or light, can degrade the potency of antimicrobials. When these compromised medicines are administered to patients or animals alike, they may not effectively eradicate the targeted pathogens, leading to partial survival of the pathogens. These surviving pathogens, having been exposed to sub-lethal doses, are more likely to evolve and develop resistance mechanisms. The review discusses the mechanism underlying this and underscores the implications of antimicrobial storage practices in relation to two of the most pressing global health challenges: AMR and CC. The review also presents specific case studies and highlights the importance of monitoring storage practices and supply chain surveillance. Furthermore, the importance of deploying genomic tools to understand the potential impact of storage conditions on the development of AMR is discussed, and antimicrobial storage highlighted as a crucial part of comprehensive strategies in the fight against AMR. ", keywords = "antibiotics, antimicrobial resistance, pharmaceutical supplies, horizontal gene transfer, climate change, one health", author = "Fagunwa, \{Omololu E.\} and Diane Ashiru-Oredope and Gilmore, \{Brendan F.\} and Simon Doherty and Oyama, \{Linda B.\} and Huws, \{Sharon A.\}", year = "2024", month = dec, day = "15", doi = "10.1016/j.scitotenv.2024.177367", language = "English", volume = "956", journal = "Science of the Total Environment", issn = "1879-1026", publisher = "Elsevier B.V.", } . Science of the Total Environment.

JOURNAL ARTICLE

Omololu Fagunwa, Reinier F Prosée, Rose S Penfold, Rasmus Andersen, Amery Gration, Sofia Kakembo, Benjamin Dominik Maier, Clare Rees-Zimmerman, Kathryn Spiller, Katherine Brown (2024). Publishers and Early-Career Researchers Working Together: Guiding Initiatives . Science Editor.

Omololu Fagunwa, Kirsty Davies, Jane Bradbury (2024). The Human Gut and Dietary Salt: The Bacteroides/Prevotella Ratio as a Potential Marker of Sodium Intake and Beyond . Nutrients.

Omololu Fagunwa, Kirsty Davies, Jane Bradbury (2024). The Human Gut and Dietary Salt: The <i>Bacteroides</i>/<i>Prevotella</i> Ratio as a Potential Marker of Sodium Intake and Beyond . Nutrients.

Omololu Ebenezer Fagunwa, Thobile Mthiyane, Ayokunle Fagunwa, Kassim Idowu Olayemi, Alaoma Alozie, Helen Onyeaka, Adenike Akinsemolu, Adegbola Ojo (2023). Priority regions for eliminating open defecation in Africa: implications for antimicrobial resistance . Environment, Development and Sustainability.

Omololu Fagunwa, Adenike Akinsemolu, Helen Onyeaka, Adewale Henry Adenuga (2023). Toward a Resilient Future: The Promise of Microbial Bioeconomy . Sustainability.

Omololu Fagunwa, Adenike Akinsemolu, Helen Onyeaka, Adewale Henry Adenuga (2023). Toward a Resilient Future: The Promise of Microbial Bioeconomy . Sustainability.

Fagunwa, O.E (2021). Child obesity prevention: Nigerian children and adolescents have fair knowledge of obesity. https://doi.org/10.1016/j.hnm.2020.200117 .

Fagunwa, O. (2020). RELIGION AND WEIGHT STATUS IN NIGERIA: ANALYSIS FROM THE NIGERIA DEMOGRAPHIC AND HEALTH SURVEY. Afr. J. HNM, 3(7):111-119. ISSN:2689-9418. DOI: 10.52589/AJHNM-QRG3Q55Q .

Ayokunle Fagunwa, Omololu Ebenezer Fagunwa (2020). Pandemic, pandemonium, and Psalm 91: In search of ultimate protection and deliverance . Christian Journal for Global Health.

Omololu Ebenezer Fagunwa, Ayokunle Oluwasanmi Fagunwa (2020). The English sweating sickness of 1485-1551 and the ecclesiastical response . Christian Journal for Global Health.

(2020). Harnessing microbial science to accelerate the United Nations sustainable development goals . Access Microbiology.

Omololu E. Fagunwa, Afolake A. Olanbiwoninu(2020). Accelerating the sustainable development goals through microbiology: some efforts and opportunities . Access Microbiology. 2. (5). Microbiology Society

(2019). Isolation and characterization of a novel exopolysaccharide secreted by Lactobacillus mucosae VG1 . Carbohydrate Research.

PREPRINT

Omololu Ebenezer Fagunwa, Thobile Mthiyane, Ayokunle Fagunwa, Kassim Idowu Olayemi, Alaoma Alozie, Helen Onyeaka, Adenike Akinsemolu, Adegbola Ojo (2023). Analyses of health surveys indicates regions of priority to eliminate open defecation in Africa and implication for antimicrobial resistance burden .

JOURNAL ISSUE

OLANBIWONINU, A. A., & FAGUNWA, O. E. (2021). SAFETY EVALUATION OF WEST AFRICAN ALKALINE FERMENTED FOODS. Journal of Advances in Food Science & Technology, 7(1), 26-37 .

OTHER

Corrigendum: Accelerating the sustainable development goals through microbiology: some efforts and opportunities @article{0eccf3a14fa249b2849a56d9b39cfdd6, title = "Corrigendum: Accelerating the sustainable development goals through microbiology: some efforts and opportunities", author = "Fagunwa, \{Omololu E.\} and Olanbiwoninu, \{Afolake A.\}", year = "2020", month = dec, day = "21", doi = "10.1099/acmi.0.000174", language = "English", volume = "2", journal = "Access Microbiology", issn = "2516-8290", publisher = "Microbiology Society", number = "12", } . Access Microbiology.

CONFERENCE PRESENTATION

Isolation and characterisation of a novel exopolysaccharide secreted by Lactobacillus mucosae VG1 @conference{06b17e8bb242430d9120758f091e80ec, title = "Isolation and characterisation of a novel exopolysaccharide secreted by Lactobacillus mucosae VG1", abstract = "A novel strain of Lactobacillus mucosae was isolated from a faecal sample of an individual who had adhered to a strict vegetarian diet for nine years. The strain displayed a ropy character when grown on plates and generated a relatively small amount (62 mg/L) of an exopolysaccharide (EPS) when grown in broth culture. The EPS eluted from a size exclusion chromatography column as a single band with a weight average molecular mass of 1.51 × 104 g/mol. Monomer analysis and sugar absolute configuration analysis confirmed that the EPS was a D-galactan. Using linkage analysis in combination with 1D and 2D-NMR spectroscopy, with spectra being recorded for both the native EPS and for the products generated by Smith degradation of the EPS, the following structure was determined for the repeat unit of the polysaccharide: This is a novel D-galactan and represents the first structure for an EPS produced by a strain of Lactobacillus mucosae to be reported.", keywords = "Glyconanoparticles, STRUCTURAL-ANALYSIS, Chemistry, Pharmaceutical, Exopolymer production, Exopolysaccharides, NMR spectroscopy, HPLC, GC-MS, Bacterial species, FOOD COMPOSITES, Polymer, Lactobacillus, Lactobacillus mucosae, Industrial biotechnology, Probiotics", author = "Omololu Fagunwa and Hafeez Ahmed and Sohaib Sadiq and Paul Humphreys and N McLay and Andrew Laws", year = "2019", language = "English", } .